Babys own umbilical cord blood for transfusion in premature newborn babies

Autologous umbilical cord blood for red cell concentrates (RCC) transfusion in preterm infants- An uncontrolled trial

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/02/007924

Enrollment

Registered

2017-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D759- Disease of blood and blood-formingorgans, unspecified

Interventions

Intervention1: Autologous umbilical cord blood: Autologous umbilical cord blood for red cell concentrates transfusion in preterm infants Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Premature infants <30 weeks gestational age and/or <1200g estimated fetal weight, who are delivered by vaginal delivery or caesarean section

Exclusion criteria

Exclusion criteria: Lack of consent Mothers positive for HIV, HBsAg, HCV or VDRL Clinical or proven chorioamnionitis Mother who opt for cord blood banking Major congenital anomalies or genetic syndromes Maternal-fetal iso-immunization

Design outcomes

Primary

Measure	Time frame
Number of Red cell concentrates transfusions from Umbilical cord bloodTimepoint: Till 3 weeks of life	—

Secondary

Measure	Time frame
â?¢ Number of UCB units of adequate quantity (15ml/kg) and quality that could be collected â?¢ Number of units of adequate quality (biochemical and hematological) o On day 7 o On day 14 o On day 21 â?¢ Incidence of transfusion reactions Timepoint: First 3 weeks of life	—

Countries

India

Contacts

Public ContactThangaraj Abiramalatha

Department of Neonatology, Sri Ramachandra University, Porur, Chennai

drbinusss@gmail.com9841283832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026